Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,035 total articles
A director at Robinhood Markets sold a significant block of company stock via a pre-arranged plan. Concurrently, the firm reported robust increases in its customer base and platform assets, while co-founder Baiju Bhatt's startup secured substantial private funding. Deutsche Bank maintained a 'Buy' rating on HOOD.
Kevin Hettrich, Chief Financial Officer of QuantumScape Corp., recently divested a portion of his holdings through a pre-arranged trading plan. This transaction occurred while the company's stock price remains highly volatile despite recent operational improvements reported in Q1 2026 earnings.
Rebeca Obregon-Jimenez, a director at FormFactor Inc., sold a substantial block of company stock totaling $484,146. This sale occurred on May 21, 2026. The transaction, involving the disposal of 3,828 shares priced at $126.475 each, originated from the vesting and subsequent sale of restricted stock units. Despite this insider activity, FormFactor …
Director Geoffrey E. Molson recently divested shares in Molson Coors Beverage Co (NASDAQ: TAP) worth $52,912. This sale occurred while the company's stock was trading near its 52-week low. Despite this transaction, Molson Coors reported robust first quarter earnings, with EPS significantly beating analyst expectations and demonstrating operational …
Chief Technology Officer Timothy Holme sold a substantial portion of his company's stock, signaling insider activity. This sale occurred against the backdrop of recent financial performance for QuantumScape Corporation, which reported Q1 2026 earnings that surpassed analyst expectations, while also facing market volatility and valuation questions.
Chief Scientific Officer Frank Yocca recently sold a block of BioXcel Therapeutics common stock, executing the transaction through a pre-arranged Rule 10b5-1 trading plan. This activity occurred alongside several significant corporate developments for the company, including the issuance of warrants to lenders and advancements in clinical trials for…
The Chief Financial Officer of BioXcel Therapeutics, Richard I. Steinhart, recently sold a portion of his common stock following the vesting of restricted stock units (RSUs). This transaction occurred against a backdrop of varied corporate activity for the company, including granting warrants to lenders, advancing Phase 2a trials, and updating its …
Javier Rodriguez, the Chief Legal Officer and Corporate Secretary at BioXcel Therapeutics, Inc. (NASDAQ:BTAI), recently sold shares of common stock totaling $7,111. This transaction was executed following the vesting of restricted stock units (RSUs) and utilized a pre-arranged trading plan. Concurrently, BTAI is making strategic moves by issuing wa…
The Chief Executive Officer of Perimeter Solutions, Inc. (NASDAQ:PRM), Haitham Khouri, executed a series of transactions between May 20 and May 22, 2026, selling approximately $7.28 million worth of the company's common stock. These sales occurred against a backdrop where PRM recently reported financial results for the first quarter of 2026 that si…
Jacob J. Schatz, Executive Vice President of Global Affairs and Chief Legal Officer at Electronic Arts Inc., recently sold a significant block of common stock valued at approximately $1.01 million. This sale occurred amidst varied market signals for EA, as the company reported fourth-quarter results that missed Wall Street expectations on earnings …
Vimal Mehta, the Chief Executive Officer and President of BioXcel Therapeutics, Inc. (NASDAQ:BTAI), executed a sale of company shares totaling $21,108 on May 20, 2026. This transaction occurred following the vesting of restricted stock units (RSUs) earlier that month. The analysis also details recent corporate developments for BioXcel Therapeutics,…
A review of filing details reveals that Moderna director Noubar Afeyan sold a significant amount of company stock. This transaction occurred in the context of an option exercise by Flagship Pioneering, LLC, which also managed the sale. Furthermore, other corporate news highlights board bylaws amendments, shareholder meetings, and new research into …
Director Yvonne Wassenaar of Arista Networks (NASDAQ:ANET) completed a sale of common stock worth approximately $136,846 on May 20, 2026. These dispositions were executed under the framework of a Rule 10b5-1 trading plan established previously. The transaction involved selling various tranches of shares accumulated through both vesting Restricted S…
Jean-Claude Carine Lamercie, a senior executive at Arrow Electronics, sold a portion of his company stock. This transaction occurred against a backdrop of significant positive operational news for the firm, including strong Q1 2026 earnings, enhanced investor metrics, and a new share repurchase program.
Cohu Inc. director Steven J. Bilodeau recently sold a substantial block of common stock. This transaction occurs against a backdrop of strong operational performance and highly positive analyst sentiment. The company reported first-quarter 2026 revenue that exceeded forecasts, alongside securing new orders for its AI testing platform, fueling multi…
The Chief Executive Officer of Five Star Bancorp (NASDAQ:FSBC), James Eugene Beckwith, divested a portion of his common stock in May 2026. This sale occurred as the bank's shares traded near their 52-week high following a substantial annual return. Separately, the institution reported strong first quarter results for 2026, surpassing market expecta…
The recent acquisition of company shares by Diebold Nixdorf's Chief Financial Officer, Thomas S. Timko, occurred amidst positive operational news for the firm. The CFO purchased 672 shares on May 22, 2026, at $74.36 per share, totaling $49,969. This insider activity follows a first quarter of 2026 marked by robust financial performance, including a…
Global Water Resources, Inc. (NASDAQ:GWRS) recently reported mixed financial results for the first quarter of 2026. Despite increasing revenue driven by organic growth and acquisitions, the company missed earnings expectations. Separately, Michael J Liebman, CFO and Corporate Secretary, acquired shares in the company's common stock via a Spouse IRA…
OneMeta Inc. (ONEI) recently saw a significant transaction involving its preferred stock, with major shareholder Rowland W Day II selling a substantial block of Series B-1 shares. This activity occurred against a backdrop of various financial maneuvers by the company, including an agreement with Avaya LLC and a notable share repurchase program.
Todd DeBonis, President and CEO of Pixelworks, Inc., recently sold a portion of his common stock following the release of restricted stock units. This transaction occurred against a backdrop of strategic operational changes reported in Q1 2026. While the market reacted positively to these shifts with an increase in premarket trading, analysts note …
The Chief Financial Officer of PIXELWORKS, INC (NASDAQ:PXLW), Aman Haley F, recently executed a stock sale. This transaction occurred against a backdrop of major corporate developments, including the reporting of Q1 2026 earnings. These reports detailed significant strategic and operational changes by the company, which have been met with positive …
The Chief Executive Officer of Rain Enhancement Technologies Holdco, Inc. recently executed several open-market purchases of the company's common stock. This buying activity occurred while the stock experienced a significant surge in value. Furthermore, the firm reported operational data detailing successful snowpack enhancement results achieved du…
The Chief Financial Officer of Sierra Bancorp (NASDAQ:BSRR), Christopher G. Treece, executed a transaction involving the sale of company stock on May 22, 2026. This activity occurred as the stock traded near its five-two-week high and followed substantial recent gains. The report also details other key corporate actions, including the declaration o…
Chief Operating Officer Ye Weiguo sold a total value of $136,653 in GYRE THERAPEUTICS, INC. common stock over two days in May 2026. These transactions occurred while the company's stock was trading near its 52-week low. Despite the insider sales, recent developments highlight strategic growth for Gyre Therapeutics, including the acceptance of a New…
The Controller of Reinsurance Group of America Inc., John W. Hayden, recently executed a series of transactions involving the company's common stock. These activities include selling shares while simultaneously acquiring others through the exercise of Stock Appreciation Rights (SARs). The report also notes RGA's strong first quarter financial resul…
